ALPHA Stock Overview
Operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia and Singapore. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Alpha IVF Group Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.33 |
| 52 Week High | RM 0.38 |
| 52 Week Low | RM 0.29 |
| Beta | 0 |
| 1 Month Change | -2.99% |
| 3 Month Change | -9.72% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 1.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALPHA | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | 0% | -0.2% | -0.7% |
| 1Y | n/a | 20.3% | 6.1% |
Return vs Industry: Insufficient data to determine how ALPHA performed against the MY Healthcare industry.
Return vs Market: Insufficient data to determine how ALPHA performed against the MY Market.
Price Volatility
| ALPHA volatility | |
|---|---|
| ALPHA Average Weekly Movement | 2.6% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in MY Market | 10.0% |
| 10% least volatile stocks in MY Market | 2.4% |
Stable Share Price: ALPHA has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: ALPHA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 150 | Colin Lee | alphaivfgroup.com |
Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia and Singapore. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and savior sibling program; preimplantation genetic testing; implantation optimisation; sperm sorting; and egg freezing, embryo freezing and cryo-storage, laparoscopic surgery, hysteroscopic surgery, 4D ultrasound scanning, and artificial intelligence-enhanced embryo selection services. It also provides various diagnostics, testing and screening procedures; cryopreservation of eggs and sperms; medical consultants; fertility, gynecological, and obstetric treatment; and other women-related healthcare and medical services.
Alpha IVF Group Berhad Fundamentals Summary
| ALPHA fundamental statistics | |
|---|---|
| Market cap | RM 1.58b |
| Earnings (TTM) | RM 54.65m |
| Revenue (TTM) | RM 170.51m |
28.9x
P/E Ratio9.3x
P/S RatioIs ALPHA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALPHA income statement (TTM) | |
|---|---|
| Revenue | RM 170.51m |
| Cost of Revenue | RM 70.35m |
| Gross Profit | RM 100.16m |
| Other Expenses | RM 45.52m |
| Earnings | RM 54.65m |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.011 |
| Gross Margin | 58.74% |
| Net Profit Margin | 32.05% |
| Debt/Equity Ratio | 0% |
How did ALPHA perform over the long term?
See historical performance and comparisonDividends
3.1%
Current Dividend Yield30%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 10:58 |
| End of Day Share Price | 2025/01/21 00:00 |
| Earnings | 2024/08/31 |
| Annual Earnings | 2024/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alpha IVF Group Berhad is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Khir Goh | AmInvestment Bank Berhad |
| Kok Chee | AmInvestment Bank Berhad |
| Siao Lee | Public Investment Bank Berhad |